# Novo Nordisk acquires all shares of Biocorp

Novo Nordisk has completed the acquisition of 100% of the shares of Biocorp, a France-based drug delivery device maker. The deal values Biocorp at approximately $164.5 million (€154 million).

- Type: Acquisition
- Announced: 2023-10-11
- Where: France
- Value: $164.5M
- Status: completed
- Products: drug delivery systems, Mallya smart sensor for pen injectors
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Novo Nordisk](https://endata.com/companies/17868.md) (acquirer)
- [Biocorp](https://endata.com/companies/73215.md) (target)

## Sources

- [drugdeliverybusiness.com](https://www.drugdeliverybusiness.com/novo-nordisk-acquires-all-shares-biocorp/), 2023-10-11: "This is a huge opportunity for all our teams since we all together are 'united by differences, powered by innovation.'"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.